Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $25.7 Million - $29 Million
-766,766 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $458,873 - $583,497
-13,710 Reduced 1.76%
766,766 $28.2 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $398,589 - $467,636
-12,554 Reduced 1.58%
780,476 $28.6 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $103,552 - $125,624
3,438 Added 0.44%
793,030 $25.9 Million
Q4 2019

Feb 19, 2020

BUY
$32.92 - $37.36 $52,606 - $59,701
1,598 Added 0.2%
789,592 $30.9 Million
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $123,137 - $159,672
-3,790 Reduced 0.48%
787,994 $28.3 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $9,392 - $10,546
-254 Reduced 0.03%
791,784 $34.3 Million
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $859,650 - $944,468
-22,924 Reduced 2.81%
792,038 $33.6 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $351,077 - $400,266
-9,126 Reduced 1.11%
814,962 $35.6 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $116,439 - $141,234
3,378 Added 0.41%
824,088 $36.3 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $280,659 - $299,211
-8,510 Reduced 1.03%
820,710 $29.8 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $33,760 - $39,167
-1,058 Reduced 0.13%
829,220 $29.4 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $60,865 - $64,580
1,830 Added 0.22%
830,278 $30.1 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $25.7 Million - $28.3 Million
828,448
828,448 $29.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.